Ki C. Chang
Chinju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
13-Ethylberberine Induces Apoptosis through the Mitochondria-Related Apoptotic Pathway in Radiotherapy-Resistant Breast Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: June 05, 2019
Sirt1 S-nitrosylation induces acetylation of HMGB1 in LPS-activated RAW264.7 cells and endotoxemic mice.
Journal: Biochemical and biophysical research communications
Published: April 11, 2018
Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Journal: Oncology reports
Published: April 03, 2018
Degradation of histone deacetylase 4 via the TLR4/JAK/STAT1 signaling pathway promotes the acetylation of high mobility group box 1 (HMGB1) in lipopolysaccharide-activated macrophages.
Journal: FEBS open bio
Published: March 27, 2018
Luteolin activates ERK1/2- and Ca2+-dependent HO-1 induction that reduces LPS-induced HMGB1, iNOS/NO, and COX-2 expression in RAW264.7 cells and mitigates acute lung injury of endotoxin mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: January 17, 2018
A limited series of synthetic tetrahydroisoquinoline alkaloids reduce inflammatory gene iNOS via inhibition of p-STAT-1 and suppress HMGB1 secretion in LPS-treated mice lung tissue.
Journal: International immunopharmacology
Published: August 18, 2017
The proximal tubular α7 nicotinic acetylcholine receptor attenuates ischemic acute kidney injury through Akt/PKC signaling-mediated HO-1 induction.
Journal: Experimental & molecular medicine
Published: August 04, 2017
Hemin Reduces HMGB1 Release by UVB in an AMPK/HO-1-dependent Pathway in Human Keratinocytes HaCaT Cells.
Journal: Archives of medical research
Published: January 02, 2017
13-Ethylberberine reduces HMGB1 release through AMPK activation in LPS-activated RAW264.7 cells and protects endotoxemic mice from organ damage.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 25, 2016
Ethyl pyruvate inhibits the acetylation and release of HMGB1 via effects on SIRT1/STAT signaling in LPS-activated RAW264.7 cells and peritoneal macrophages.
Journal: International immunopharmacology
Published: July 12, 2016
13-Methylberberine reduces HMGB1 release in LPS-activated RAW264.7 cells and increases the survival of septic mice through AMPK/P38 MAPK activation.
Journal: International immunopharmacology
Published: May 31, 2016
(S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Journal: European journal of pharmacology
Published: May 02, 2016
Last Updated: 09/26/2026